UBS Group AG 13D/13G Filings for Evogene Ltd. (EVGN)

UBS Group AG 13D and 13G filings for Evogene Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-08
06:16 am
Sale
2020-12-3113GEvogene Ltd.
EVGN
UBS Group AG0
0.000%
-136,983decrease
(Position Closed)
Filing